These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 39338952)
21. Anti-influenza A virus activity of two Newtonia species and the isolated compound myricetin-3-o-rhamnoside. Motlhatlego KE; Mehrbod P; Fotouhi F; Abdalla MA; Eloff JN; McGaw LJ BMC Complement Med Ther; 2021 Mar; 21(1):92. PubMed ID: 33726731 [TBL] [Abstract][Full Text] [Related]
22. Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells. Boltz D; Peng X; Muzzio M; Dash P; Thomas PG; Margitich V Antivir Chem Chemother; 2018; 26():2040206618811416. PubMed ID: 30466301 [TBL] [Abstract][Full Text] [Related]
23. Germacrone inhibits early stages of influenza virus infection. Liao Q; Qian Z; Liu R; An L; Chen X Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670 [TBL] [Abstract][Full Text] [Related]
24. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus. de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305 [TBL] [Abstract][Full Text] [Related]
25. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses. Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918 [TBL] [Abstract][Full Text] [Related]
26. Porous gold nanoparticles for attenuating infectivity of influenza A virus. Kim J; Yeom M; Lee T; Kim HO; Na W; Kang A; Lim JW; Park G; Park C; Song D; Haam S J Nanobiotechnology; 2020 Mar; 18(1):54. PubMed ID: 32209114 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of influenza virus replication by Apiaceae plants, with special reference to Peucedanum japonicum (Sacna) constituents. Kanazawa R; Morimoto R; Horio Y; Sumitani H; Isegawa Y J Ethnopharmacol; 2022 Jun; 292():115243. PubMed ID: 35358620 [TBL] [Abstract][Full Text] [Related]
28. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo. Zhang Y; Yao J; Qi X; Liu X; Lu X; Feng G Antivir Ther; 2017; 22(7):599-611. PubMed ID: 28272019 [TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus. Derksen A; Kühn J; Hafezi W; Sendker J; Ehrhardt C; Ludwig S; Hensel A J Ethnopharmacol; 2016 Jul; 188():144-52. PubMed ID: 27178637 [TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. Komatsu T; Kido N; Sugiyama T; Yokochi T Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):1-7. PubMed ID: 22856509 [TBL] [Abstract][Full Text] [Related]
31. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo. Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217 [TBL] [Abstract][Full Text] [Related]
34. Effects and mechanism of Qingke Pingchuan granules against influenza virus infection. He L; Cao J; Xie X; Zhang Y; Zhang X; Wang H; Ma L Arch Virol; 2024 May; 169(6):130. PubMed ID: 38807015 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Xiang D; Zheng Y; Duan W; Li X; Yin J; Shigdar S; O'Connor ML; Marappan M; Zhao X; Miao Y; Xiang B; Zheng C Int J Nanomedicine; 2013; 8():4103-13. PubMed ID: 24204140 [TBL] [Abstract][Full Text] [Related]
36. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. Smee DF; Morrison AC; Barnard DL; Sidwell RW J Virol Methods; 2002 Oct; 106(1):71-9. PubMed ID: 12367731 [TBL] [Abstract][Full Text] [Related]
37. [Effect and mechanism of Mahuang Tang against influenza A/H1N1 virus Wei WY; Wan HT; Yu L; Lu YY; He Y Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):563-570. PubMed ID: 29600623 [TBL] [Abstract][Full Text] [Related]
38. Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses. Aggarwal M; Leser GP; Lamb RA J Virol; 2020 Feb; 94(6):. PubMed ID: 31896588 [TBL] [Abstract][Full Text] [Related]
39. Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells. Saengchoowong S; Nimsamer P; Khongnomnan K; Poomipak W; Praianantathavorn K; Rattanaburi S; Poovorawan Y; Zhang Q; Payungporn S Exp Biol Med (Maywood); 2022 Aug; 247(15):1335-1349. PubMed ID: 35666095 [TBL] [Abstract][Full Text] [Related]
40. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus. Moradi MT; Karimi A; Rafieian-Kopaei M; Fotouhi F Microb Pathog; 2017 Sep; 110():42-49. PubMed ID: 28629724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]